Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mondi Q1 sales volume growth offsets lower average selling prices

(Sharecast News) - Packaging and paper firm Mondi said on Thursday that higher sales volumes, good cost control and fewer planned maintenance shuts during Q125 had helped to offset lower average selling prices when compared to Q424. Mondi said underlying earnings had come to €290.0m, including a forestry fair value gain of €2.0m, with stronger order books driving higher sales volumes in its corrugated and flexible packaging units, supported by "a solid performance" in the downstream converting operations.

The FTSE 100-listed firm noted that while average selling prices in Q125 were lower than Q424 following selling price declines towards the end of FY24, paper price increases have been implemented to largely recover the declines over the last few months.

In its uncoated fine paper arm, Mondi said market conditions remained "muted" and also saw lower average selling prices in Q125 when compared to Q424.

Chief executive Andrew King said: "In the first quarter of the year we have seen stronger order books driven by increased demand for our sustainable packaging products. This has supported recent price increases which we expect to come through from the second quarter.

"Towards the end of the first quarter, global trade tensions heightened macroeconomic uncertainty. While the direct impact of announced tariffs on our operations is limited, we remain mindful of the potential second order impacts that could affect trade flows, consumer confidence and supply chains."

As of 0915 BST, Mondi shares were up 3.60% at 1,150.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.